Cart
sales@molnova.com
CDK2 inhibitor 73
CAS No. 2079895-42-2
CDK2 inhibitor 73( CDK2-IN-73 | CDK2 IN 73 | CDK2IN73 | CDK2 inhibitor 73 )
Catalog No. M13236 CAS No. 2079895-42-2
A potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 223 | In Stock |
|
| 5MG | 202 | In Stock |
|
| 10MG | 321 | In Stock |
|
| 25MG | 550 | In Stock |
|
| 50MG | 737 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCDK2 inhibitor 73
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM).
-
DescriptionA potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM).
-
In Vitro——
-
In Vivo——
-
SynonymsCDK2-IN-73 | CDK2 IN 73 | CDK2IN73 | CDK2 inhibitor 73
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2079895-42-2
-
Formula Weight442.497
-
Molecular FormulaC23H18N6O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20.83 mg/mL (47.07 mM)
-
SMILESO=S(C1=CC=C(NC2=NC(C3=CC(C4=CC=CC=C4)=CC=C3)=C5N=CNC5=N2)C=C1)(N)=O
-
Chemical Name4-((6-([1,1'-biphenyl]-3-yl)-9H-purin-2-yl)amino) benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Coxon CR, et al. J Med Chem. 2017 Mar 9;60(5):1746-1767.
molnova catalog
related products
-
CAN-508
CAN-508 is a potent, selective CDK9 inhibitor with IC50 of 0.35 uM (CDK9/cyclin T1), displays >35 fold selectivity over CDK1/2/4/7 (IC50=13.5-70 uM).
-
23-epi-26-Deoxyactei...
23-epi-26-Deoxyactein has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.
-
SR-4835
SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13(CDK12: IC50=99 nM Kd=98 nM; CDK13: Kd=4.9 nM) which disables triple-negative breast cancer (TNBC) cells.
